AMALGAMATED BANK - DICERNA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$250,000
-48.5%
12,379
-4.8%
0.00%
-50.0%
Q2 2021$485,000
+102.1%
13,003
+38.8%
0.00%
-55.6%
Q1 2021$240,000
+5.7%
9,368
-9.1%
0.01%0.0%
Q4 2020$227,000
+24.7%
10,301
+2.0%
0.01%
+12.5%
Q3 2020$182,000
-31.1%
10,097
-2.9%
0.01%
-33.3%
Q2 2020$264,000
+23.4%
10,399
+7.2%
0.01%
+200.0%
Q4 2019$214,0009,7000.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,705,392$43,607,0007.88%
Bain Capital Life Sciences Investors, LLC 3,080,237$78,762,0004.46%
DAFNA Capital Management LLC 587,756$15,029,0003.57%
RTW INVESTMENTS, LP 7,463,291$190,836,0002.98%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$5,114,0002.79%
Evolutionary Tree Capital Management, LLC 122,473$3,132,0001.85%
Parkman Healthcare Partners LLC 303,268$7,755,0001.80%
Eagle Health Investments LP 161,125$4,120,0001.62%
BRIDGER MANAGEMENT, LLC 588,910$15,058,0001.41%
Woodline Partners LP 1,777,000$45,438,0001.01%
View complete list of DICERNA PHARMACEUTICALS INC shareholders